Appointments
Med tech industry service provider Veranex has announced the appointment of industry veteran Tom Daulton as chief executive officer (CEO). Former CEO David Dockhorn is assuming the newly created role of chief operating officer (COO). Daulton has over 30 years of healthcare leadership experience, joining from National Dentex Labs, where he served as chairman and [...]
Clinical stage biotechnology company AnHeart Therapeutics has announced two new appointments. The company, which develops novel precision oncology therapeutics, has appointed Heinrich Farin, M.D. as Senior Medical Director of Clinical Research and Michael J. Humphries, Ph.D., as VP and Head of US Medical Affairs. Dr Farin has more than 20 years of experience in clinical [...]
Trade association MedTech Europe has announced the appointment of Oliver Bisazza as its new Chief Executive Officer, with effect from January 2, 2023. Bisazza will succeed Serge Bernasconi who has announced his retirement. The new CEO has more than 15 years of professional experience in Brussels, including industrial policies roles in trade associations representing medtech [...]
Global health solutions company Maternova, Inc. has announced the appointment of Luna M. Mehrain, MD, MSc, as Chief Medical Officer. The obstetrician, gynaecologist and strategic leader in reproductive, maternal and neonatal health, will assess the efficacy, safety and usability of Maternova’s diagnostics and therapeutic medical innovations. Dr Mehrain will also be responsible for training the [...]
Sudo Biosciences, a biopharmaceutical company that designs and develops a broad pipeline of TYK2 (tyrosine kinase 2) inhibitors, has announced the appointment of Imran Babar, Ph.D., as chief business officer. Dr Babar has extensive experience in in healthcare strategy, life sciences finance, operations and business development. Scott Byrd, CEO, Sudo Biosciences, said: “Imran brings to [...]
Prilenia Therapeutics B.V. has announced the appointment of Anne Sullivan as Chief Business Officer. Sullivan will lead all strategic collaboration activities at the clinical stage biotechnology company, which develops novel therapeutics to slow the progression of neurodegenerative and neurodevelopmental disorders. Dr Michael R. Hayden, CEO and Founder of Prilenia, said: “As Prilenia prepares for key [...]
SP Industries, Inc has announced the appointment of Kevin Sutherby as its new President. The company is a global provider of fill-finish drug manufacturing solutions, lyophilizers and laboratory equipment and supplies. Sutherby has more than years’ experience leading global manufacturing companies, including senior leadership positions at Danaher and Fortive and most recently as Senior Vice [...]
Darren Goode, who previously led health tech company Elvie to become a $26m global brand, will now turn his efforts to innovative, home fertility femtech firm, Béa Fertility… A former global chief marketing officer at Elvie has been appointed as a leading advisor at femtech startup Béa Fertility - where he plans to help the [...]
Biotechnology company Aspect Biosystems has announce the appointment of three new members to its Board of Directors: Dr Nancy Krieger, Dr Don Haut and Dr Devyn Smith. The company develops bioprinted tissue therapeutics to transform how diseases are treated. Dr Don Haut is currently the CEO of discovery-stage, non-viral gene therapy company Carmine Therapeutics. Originally [...]
General Electric (GE) has announced the first Board of Directors for its independent healthcare spinoff, GE HealthCare. The company is set to be created following a spinoff slated for the first week of January 2023, subject to board approval. Lawrence Culp, Jr., Chairman and CEO, GE, and CEO, GE Aerospace, will serve as Non-Executive Chairman [...]
